Mittendorf, EA. <br/><br/>
Primary analysis of a prospective, randomized, single-blinded phase 11 trial evaluating the HER2 peptide AE37 vaccine in breast cancer patienrs to prevent recurrence 

 - 2016 ( Vol.27, num. 7) 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Breast Cancer<br/>Cáncer de Mama